3 Undervalued Stocks to Buy Under $40 Right Now
The Motley Fool
Published Apr 08, 2021 09:54
Updated Apr 08, 2021 10:15
3 Undervalued Stocks to Buy Under $40 Right Now
It can be hard to find stocks that are truly undervalued, especially in a volatile market. But if you’re a long-term investor, don’t let volatility scare you. Finding value stocks is the surest way to create a strong investment portfolio. So consider these four stocks today, all trading below $40 per share.
RioCan REIT As the pandemic slowly comes to an end, retail should start to pick up again. That’s why investors should consider owning a value stock like RioCan REIT (TSX:REI.UN), a company with mixed-use properties located in high-density urban centres. Yet shares are only up 42% in the last year.
While the company may have a 90% dependency on retail, it’s the mixed-use part that has investors excited. RioCan currently has residential spaces above several of its retail businesses, and 14 properties under development. It’s this strategy that will see continued growth in the years to come.
The stock is valuable at 0.8 times book value, and 4.4 times sales. It also offers investors a strong 4.93% dividend yield. With shares trading at around $19.50, that would give you $246 per year from a $5,000 investment.
NorthWest REIT Yes, another REIT but for a great reason! This stock didn’t have a downturn; rather, it simply soared higher. Yet shares are still a bargain for NorthWest Healthcare Properties REIT (TSX:NWH.UN), growing 60% in the last year alone.
The company has a strong 97% occupancy rate with an average lease agreement of 14.5 years! That’s from a diverse range of properties around the world, all within the necessary health sector. So this is an excellent option for any portfolio. Investors should continue to see growth from this company as it continues to acquire new healthcare business.
Yet the stock is quite valuable at 1.4 times book value, and 5.5 times sales. You also get another solid 6.18% dividend yield. Shares are currently at $13 per share, bringing in $307 per year from a $5,000 investment.
CloudMD While CloudMD Software & Services Ltd. (TSXV:DOC) may have risen substantially in the last year, it’s still a value stock given its future outlook. The telehealth company continues to grow through acquisition, bringing in more and more revenue that seems to have no ceiling. Shares have followed suite, up a whopping 378% in the last year alone! Yet shares are down about 10% since the beginning of the year, leaving a prime opportunity for investors to jump in.
It’s this growth strategy that has investors continuously interested in CloudMD stock. The company recently closed yet another acquisition and there seems to be no end in sight. The company can now boast to be a telehealth provider for several medical industries, ranging from physiotherapy to physicians and everything in between. Since there’s no limit to healthcare, there’s really no limit to this stock either.
Get The App
Yet again, the stock has a reasonable 6.2 times book value, though it’s a bit high according to sales. What investors need to decide is whether this is a great long-term buy for their portfolio. While it may not have a dividend, analysts expect the stock to practically double in a year’s time, which makes it undervalued in my books.
The post 3 Undervalued Stocks to Buy Under $40 Right Now appeared first on The Motley Fool Canada.
Fool contributor Amy Legate-Wolfe owns shares of NORTHWEST HEALTHCARE PPTYS REIT UNITS. The Motley Fool recommends NORTHWEST HEALTHCARE PPTYS REIT UNITS.
The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2021
This Article Was First Published on The Motley Fool
Written By: The Motley Fool
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.